In short: Saw palmetto has shown some positive signals in small, short studies of pattern hair loss. The research does not establish that every capsule or scalp product works, and it leaves long-term benefit and safety uncertain.
Saw palmetto has produced some encouraging results in hair-loss studies, but the evidence is too limited and product-specific to show that it works reliably. A 2020 systematic review found positive signals across oral and topical products. It found too few high-quality trials, inconsistent outcome measures and frequent use of products with several active ingredients (Evron and colleagues, 2020).
Hair loss has many possible causes. The NHS hair loss guidance advises seeing a GP to get an idea of the cause before approaching a commercial hair clinic.
Does saw palmetto work for hair loss?
Nine reports involved 381 people. These included four randomised controlled trials, two prospective cohorts and three smaller reports. Different studies examined different diagnoses, oral supplements, scalp products and combinations of ingredients, so their results do not establish one reliable effect for saw palmetto itself (Evron and colleagues, 2020).
A newer randomised trial tested one standardised saw palmetto oil. Researchers assigned 80 adults with mild to moderate androgenetic alopecia to four groups: an oral product, its placebo, a topical lotion or its placebo. Seven participants did not complete the study. The researchers analysed the 73 completers rather than everyone originally assigned (Sudeep and colleagues, 2023).
Results varied considerably by measured outcome. At 16 weeks, both active groups had lower hair-shedding scores than their respective placebo groups, and the change in measured hair density from baseline favoured the active groups. Hair thickness did not differ significantly between an active product and its placebo, and neither active group showed a significant change in the ratio of growing to resting hairs. Most topical users reported no change on the study’s self-assessment questionnaire (Sudeep and colleagues, 2023).
Four small groups, a short follow-up and an analysis limited to completers make the result uncertain. A larger, longer independent trial may produce a different estimate (Sudeep and colleagues, 2023).
What exactly did the recent trial test?
The trial tested one proprietary oil extract made by a particular manufacturer. Researchers used a standardised extract in two distinct formulations: a swallowed capsule and a lotion applied to the scalp and washed off after a set period. Different capsules, leave-on serums, shampoos and blended supplements fall outside this trial (Sudeep and colleagues, 2023).
Participants were healthy adults aged 18 to 50 in India with mild to moderate androgenetic alopecia. The trial excluded several other forms of alopecia, scalp disease, endocrine abnormalities, significant chronic conditions, smoking and recent use of various hair-loss interventions. It therefore cannot answer how the product would perform for sudden shedding, patchy loss, scarring hair loss or an unassessed medical cause (Sudeep and colleagues, 2023).
Androgenetic alopecia is one specific diagnosis. In men, it usually follows a receding frontal hairline and thinning over the top of the head, while hair at the sides and back is spared. Diagnosis usually draws on the history, distribution and scalp examination (British Association of Dermatologists).
The paper also has a commercial limitation. Several authors worked for the company that manufactured the proprietary extract. The researchers reported blinding and placebo controls, which reduce some forms of bias, but independent replication would show whether the result holds outside a manufacturer-linked study (Sudeep and colleagues, 2023).
Why do products and routes matter?
A label that says "saw palmetto" does not describe one standard hair-loss product. The 2020 review covered oral and topical routes, several diagnoses and formulations that often contained vitamins, minerals or other active ingredients. Its authors could not perform a meta-analysis because the results and measurement methods were not standardised. They also said the specific contribution of saw palmetto was often impossible to separate from the rest of a formulation (Evron and colleagues, 2020).
A swallowed extract and a scalp product expose the body differently. Even within the 2023 trial, the oral and topical formulations did not produce identical questionnaire or laboratory findings. Evidence for that lotion cannot be transferred to a shampoo that is rinsed away quickly, and evidence for that capsule cannot validate another extract with different accompanying ingredients (Sudeep and colleagues, 2023).
UK regulation leaves the clinical evidence question open. The NHS guidance on herbal medicines says herbal medicines are not tested in the same way as standard medicines to establish how well they work. A Traditional Herbal Registration mark shows that a product is licensed for use in England and meets safety standards. It does not report a tested hair-growth result.
What does the research leave unanswered?
The trial lasted only 16 weeks. It did not report follow-up after the intervention ended, so it cannot show whether any difference persists, increases or disappears later. The authors identified the short duration and small sample as limitations (Sudeep and colleagues, 2023).
The study included men and women, but it reported the efficacy outcomes for each product group rather than establishing a dependable result for either sex separately. Because it excluded many health conditions and other causes of hair loss, its safety and outcome findings should not be transferred to those groups (Sudeep and colleagues, 2023).
The trial measured a change in a circulating hormone marker in its oral group. That laboratory marker did not measure visible scalp coverage or lasting regrowth. Density and shedding favoured the active products, while hair thickness and the growing-to-resting hair ratio did not separate clearly from placebo (Sudeep and colleagues, 2023).
The broader review found modest positive results alongside small samples, weak comparison groups, qualitative measures, commercial conflicts and products that combined saw palmetto with other ingredients. Larger independent trials using the same formulation and consistent outcomes are still needed (Evron and colleagues, 2020).
Risks and what can go wrong
Long-term safety evidence remains uncertain. In the 2023 study, ten participants had mild events such as colds or headaches, which investigators judged unrelated to the products, and no serious adverse events were reported. With 73 completers, the study offered limited evidence about uncommon effects (Sudeep and colleagues, 2023).
Across earlier hair-loss reports, the systematic review described nausea, constipation and diarrhoea with oral products. Topical reports included cold sensation, mild burning, itching, forehead acne and allergic contact dermatitis. The review also noted that long-term safety could not be assessed reliably from the available studies (Evron and colleagues, 2020).
The NHS says some herbal medicines can interact with prescribed and non-prescription medicines. Suitability may also differ during pregnancy or breastfeeding and for people with liver or kidney problems. Its guidance directs people using other medicines to check with a pharmacist (NHS: Herbal medicines and complementary therapies).
There is also a risk of treating the label rather than the cause. Illness, stress, weight loss and iron deficiency are among the temporary causes listed by the NHS, while pattern hair loss can be permanent. A supplement trial in diagnosed androgenetic alopecia cannot identify why an individual is losing hair (NHS: Hair loss).
Questions to ask the clinic
If saw palmetto appears in a clinic’s plan or product list, ask questions that keep the evidence tied to the product and diagnosis:
- What diagnosis do you think explains my hair loss, and who made that assessment?
- Is the evidence you are citing about an oral product, a scalp lotion, a serum or a shampoo?
- Was this exact formulation tested, or does it only share one named ingredient with the study product?
- How many people were in the active and control groups, and how many completed the study?
- Which outcomes changed: shedding, density, thickness, photographs or participant ratings?
- How long did the study last, and was there any follow-up after the product was withdrawn?
- Who funded the research or supplied the product, and have independent researchers repeated it?
Talk it through
If the cause of your hair loss has been professionally assessed and you are considering surgery, GetHair can arrange a free consultation with a partner clinic. The partner clinic assesses suitability and any proposed procedure; GetHair arranges the introduction.